OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A Review on Emerging Drug Targets in Treatment of Schizophrenia
Hemen S. Ved, Gaurav Doshi
Current Drug Targets (2020) Vol. 21, Iss. 15, pp. 1593-1605
Closed Access | Times Cited: 7
Hemen S. Ved, Gaurav Doshi
Current Drug Targets (2020) Vol. 21, Iss. 15, pp. 1593-1605
Closed Access | Times Cited: 7
Showing 7 citing articles:
The Role of Photobiomodulation to Modulate Ion Channels in the Nervous System: A Systematic Review
Zhixin Zhang, Zhiyu Zhang, Peng Liu, et al.
Cellular and Molecular Neurobiology (2024) Vol. 44, Iss. 1
Open Access | Times Cited: 4
Zhixin Zhang, Zhiyu Zhang, Peng Liu, et al.
Cellular and Molecular Neurobiology (2024) Vol. 44, Iss. 1
Open Access | Times Cited: 4
In Silico Screening of Novel α1-GABAA Receptor PAMs towards Schizophrenia Based on Combined Modeling Studies of Imidazo [1,2-a]-Pyridines
Xiaojiao Zheng, Chenchen Wang, Na Zhai, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9645-9645
Open Access | Times Cited: 16
Xiaojiao Zheng, Chenchen Wang, Na Zhai, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9645-9645
Open Access | Times Cited: 16
Kappa Opioid Receptor Antagonists as Potential Therapeutics for Mood and Substance Use Disorders
Brian Reed, Eduardo R. Butelman, Mary Jeanne Kreek
Handbook of experimental pharmacology (2020), pp. 473-491
Closed Access | Times Cited: 16
Brian Reed, Eduardo R. Butelman, Mary Jeanne Kreek
Handbook of experimental pharmacology (2020), pp. 473-491
Closed Access | Times Cited: 16
Effects of Early Risperidone Treatment on Metabolic Parameters in Socially Isolated Rats—Implication of Antipsychotic Intervention across Developmental Stages of Schizophrenia
Nian‐Sheng Tzeng, Yu-Yin Yang, Chen-Cheng Lin, et al.
Journal of Integrative Neuroscience (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Nian‐Sheng Tzeng, Yu-Yin Yang, Chen-Cheng Lin, et al.
Journal of Integrative Neuroscience (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Update on Oxytocin, Phosphodiesterase, Neurokinin, Glycine as a Therapeutic Approach in the Treatment of Schizophrenia
Gaurav Doshi, Nirav Bhatia, Hemen Ved, et al.
CNS & Neurological Disorders - Drug Targets (2022) Vol. 22, Iss. 7, pp. 994-1007
Closed Access | Times Cited: 2
Gaurav Doshi, Nirav Bhatia, Hemen Ved, et al.
CNS & Neurological Disorders - Drug Targets (2022) Vol. 22, Iss. 7, pp. 994-1007
Closed Access | Times Cited: 2
The 3/4- and 3/6-Subfamily Variants of α-Conotoxins GI and MI Exhibit Potent Inhibitory Activity against Muscular Nicotinic Acetylcholine Receptors
Xiaoli Ma, Qiuyuan Huang, Shuo Yu, et al.
Marine Drugs (2021) Vol. 19, Iss. 12, pp. 705-705
Open Access | Times Cited: 2
Xiaoli Ma, Qiuyuan Huang, Shuo Yu, et al.
Marine Drugs (2021) Vol. 19, Iss. 12, pp. 705-705
Open Access | Times Cited: 2
Evaluation of antipsychotic medication adherence and its relation to negative and positive psychiatric symptoms
Maher Khdour, Aroub Salman
Journal of Pharmaceutical Health Services Research (2022) Vol. 13, Iss. 3, pp. 224-229
Closed Access
Maher Khdour, Aroub Salman
Journal of Pharmaceutical Health Services Research (2022) Vol. 13, Iss. 3, pp. 224-229
Closed Access
